Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma-Reference-Cited by-同舟云学术

Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma

Published:2021-02-01 Issue:2 Volume:31 Page:217-223
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Sasaki Takahiro¹,Miyauchi Akira²,Ito Yasuhiro²,Kudo Takumi³,Kanemura Nobuaki¹,Sano Tsutomu¹,Kawano Shiori²,Yamamoto Masatoshi²,Fujishima Makoto²,Masuoka Hiroo²,Higashiyama Takuya²,Kihara Minoru²,Miya Akihiro²

Affiliation:

1. Department of Head and Neck Surgery, Kuma Hospital, Kobe, Japan.

2. Department of Surgery, Kuma Hospital, Kobe, Japan.

3. Department of Internal Medicine, Kuma Hospital, Kobe, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2020.0319

Reference17 articles.

1. Increasing Incidence of Thyroid Cancer in the United States, 1973-2002

2. Current Thyroid Cancer Trends in the United States

3. Korea's Thyroid-Cancer “Epidemic” — Screening and Overdiagnosis

4. An Observation Trial Without Surgical Treatment in Patients with Papillary Microcarcinoma of the Thyroid

5. An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancement on CT for preoperative diagnosis of metastatic lymph nodes in thyroid cancer: a comparison across experience levels;European Radiology;2024-07-09

2. Tumor Growth Kinetics Based on Initial Tumor Volume Doubling Time in Active Surveillance of Low-Risk Papillary Thyroid Carcinoma;Thyroid®;2024-07-01

3. Active Surveillance and Conversion Surgery for Low-Risk Thyroid Cancer—The Disconnect Between Literature and Practice;JAMA Otolaryngology–Head & Neck Surgery;2024-05-15

4. Active Surveillance for Low-Risk Papillary Thyroid Carcinoma as an Acceptable Management Option with Additional Benefits: A Comprehensive Systematic Review;Endocrinology and Metabolism;2024-02-29

5. Active Surveillance for Low-Risk Papillary Thyroid Carcinoma as an Acceptable Management Option with Additional Benefits: A Comprehensive Systematic Review;Endocrinology and Metabolism;2024-02-29